Urogen Pharma (URGN) has released an update to notify the public and investors about a regulation fd disclosure.
UroGen Pharma Ltd. presented at the Sixth Annual Guggenheim Healthcare Talks Conference on February 8, 2024, sharing insights that are of particular interest to investors and market watchers. While the presentation is informative, it’s important to note that the content is not filed under the Securities Exchange Act of 1934 and does not carry the same legal weight as formally filed documents. Nonetheless, it offers valuable information for those tracking the company’s progress and strategies.
For further insights into URGN stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
